Enfusion, Inc.
ENFN · NYSE
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 3.5% | 3.5% | 2.9% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 69% | 68.1% | 67.7% | 66.3% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 3% | 11.6% | 11.3% | 3.2% |
| Net Income | $0 | $0 | $0 | -$0 |
| % Margin | 0.2% | 2.8% | 3.7% | -1.1% |
| EPS Diluted | 0.001 | 0.015 | 0.014 | -0.006 |
| % Growth | -94.1% | 7% | 336.7% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | -$0 |